key: cord-1044494-0ug2j42l
authors: Rowlands, Alex V.; Kloecker, David E.; Chudasama, Yogini; Davies, Melanie J.; Dawkins, Nathan P.; Edwardson, Charlotte L.; Gillies, Clare; Khunti, Kamlesh; Razieh, Cameron; Islam, Nazrul; Zaccardi, Francesco; Yates, Tom
title: Association of Timing and Balance of Physical Activity and Rest/Sleep With Risk of COVID-19: A UK Biobank Study
date: 2020-10-31
journal: Mayo Clin Proc
DOI: 10.1016/j.mayocp.2020.10.032
sha: 7535f0ed420ea6b3c1367e2556b57b104af34960
doc_id: 1044494
cord_uid: 0ug2j42l

Behavioural lifestyle factors are associated with cardiometabolic disease and obesity, which are risk factors for COVID-19. We aimed to investigate whether physical activity, and the timing and balance of physical activity and sleep/rest, were associated with SARS-CoV-2 positivity and COVID-19 severity. Data from 91,248 UK Biobank participants with accelerometer data, complete covariate and linked COVID-19 data to 19th July 2020 were included. The risk of SARS-CoV-2 positivity and COVID-19 severity, in relation to overall physical activity, moderate-to-vigorous physical activity (MVPA), balance between activity and sleep/rest, and variability in timing of sleep/rest, was assessed with adjusted logistic regression. Of 207 individuals with a positive test, 124 were classified as having a severe infection. Overall physical activity and MVPA were not associated with severe COVID-19, while a poor balance between activity and sleep/rest was (OR per standard deviation: 0.71 [95% CI: 0.62, 0.81]). This was related to higher daytime activity being associated with lower risk (OR 0.75 [0.61, 0.93]) but higher movement during sleep/rest with higher risk (OR 1.26 [1.12, 1.42]) of severe infection. Greater variability in timing of sleep/rest was also associated with increased risk (OR 1.21 [1.08, 1.35]). Results for testing positive were broadly consistent. In conclusion, these results highlight the importance of not just physical activity, but also quality sleep/rest and regular sleep/rest patterns, on risk of COVID-19. Our findings indicate the risk of COVID-19 was consistently ∼1.2 times higher per ∼40-minute increase in variability in timing of proxy measures of sleep, indicative of irregular sleeping patterns.

There is evidence that the risk of COVID-19 is higher in people with cardiometabolic diseases [1] . Recent research also suggests that the risk is associated with lifestyle-related factors, including obesity [2] and self-reported slow walking pace [3] , a marker of physical fitness.

There has been limited attention on the risk of COVID-19 and behavioural lifestyle factors.

Low levels of physical activity are known to be associated with increased risk of cardiometabolic disease, obesity and lower fitness [4] . Further, evidence suggests that irregular sleep timing and increased variability in sleep duration are detrimentally associated with cardiovascular disease risk and markers of cardiometabolic health [5] . This suggests that a balance between active behaviours and quality sleep/rest across the 24-hour day is important for cardiometabolic health. We hypothesise that these behavioural factors may similarly influence the risk of COVID-19.

Our aim was to investigate whether device-measured physical activity, the balance between activity during waking hours and the main sleep/rest period during the day, and the timing of the main sleep/rest and activity periods are associated with the risk of testing positive for SARS-CoV-2 and developing severe J o u r n a l P r e -p r o o f Methods We used data from UK Biobank (application 36371), a prospective cohort of >500,000 adults aged 40-69 years [6] . Assessments were conducted between March 2006 and July 2010 with data on 24 h movement patterns from Axivity AX3 wrist-worn accelerometers (Axivity, Newcastle, UK) in >100,000 adults gathered between June 2013 and December 2015 [7] . UK Biobank data are linked to national SARS-CoV-2 laboratory test data through Public Health England's Second Generation Surveillance System; data were available from 16 th March 2020 to 19 th July 2020 and included specimen origin (hospital inpatient vs other): a positive test result for SARS-CoV-2 with hospitalisation was considered as evidence of a severe infection in line with guidance for this dataset [8] . Two SARS-CoV-2 outcomes were used: 1) severe infection with SARS-CoV-2; 2) positive test result for SARS-CoV-2

Analyses were restricted to English centres, individuals with known sleep disorders (identified by ICD10 code G47 in UK Biobank) and those who had died before 16 th March 2020 were excluded. Participant characteristics, including body mass index (BMI), sex, ethnicity and self-reported sleep duration were collected at the baseline assessment.

For each participant, accelerometer data (5-second epoch time series) were extracted from UK Biobank [7] and converted to R-format for processing and analysis with GGIR (version 1.11-0, http://cran.r-project.org) [9] . Participants were excluded if they failed calibration (including those not calibrated on their own data), had fewer than three days of valid wear (defined as >16 h per day), or wear data were not present for each 15 min period of the 24 h cycle.

J o u r n a l P r e -p r o o f Accelerometer outcomes, detailed in Table 1 , were averaged across valid days and divided into three categories: standard physical activity outcomes; the balance between activity level and sleep/rest; and the variability in timing of activity and sleep/rest.

Logistic regression was used to assess associations of a severe infection with SARS-CoV-2 (N=124) with no test or a negative test result (whole cohort, N=91,041) as comparator (model 1) and a positive test result (N=207) with a negative result (N=2009) as comparator (model 2).

For Model 1, participants who tested positive for COVID-19 but were not classified as severe (i.e. they tested positive in the community, N=83) were excluded. This was because it is possible these individuals went on to develop severe COVID-19 but were not retested on hospital admission. Model 1 can be interpreted as the overall population level risk of being admitted to hospital with COVID-19 during the linkage period within UK Biobank. This population level method of assessing risk is commonly reported within COVID-19 risk factor research, and of value here as it enables comparison to the literature in terms of how the risk factors assessed compare to other commonly reported risk factors (e.g. obesity) [3, 10] .

Model 2 relates specifically to the tested population and can be interpreted as the risk of a positive test in anyone within UK Biobank who has been tested for COVID-19.

The physical activity and rest variables listed in Table 1 were used as independent variables.

These variables were standardised prior to entry into the models and the Odds Ratios (OR) per standard deviation (SD) reported for ease of comparison across variables.

In model 2, regressions were adjusted for the following potential confounders selected on current clinical knowledge: age on 16th March 2020, sex, ethnicity, Townsend Deprivation Index, number of people in household, fruit/vegetable consumption, red meat consumption, smoking status, alcohol intake, number of self-reported cancers and non-cancer illnesses, and number of treatments or medications taken. The model for severity of infection (model 1) was adjusted for key demographic variables only (age, sex and ethnicity) due to the smaller number of outcome events. The activity during waking hours (3, Table 1 ) and amount of movement during sleep/rest (4, Table 1 ) were additionally mutually adjusted for one another and for sleep duration. When assessing the balance between activity and sleep/rest (5, Table   1 ), and the variability in timing of activity and sleep/rest (6-8, Table 1 ), sleep duration was added to the models. Finally, when assessing the variability in timing of activity and sleep/rest (6-8, Table 1 ) overall activity was also added to the models. Sensitivity analyses 1) To allow for differences in sleep duration, we conducted analyses with the average acceleration and timing of the least active 6 hours rather than 8 hours;

2) Assuming individuals testing positive in the community to be non-severe, we added them to the comparator group for severe infection with SARS-CoV-2 (severe infection N=124, comparator group N=91,124);

3) We did not adjust for BMI in our main analyses as it is potentially on the causal pathway from physical activity to COVID-19 risk. However, we carried out sensitivity analyses for: i) 4) While we controlled for deprivation and household size, it is difficult to determine risk due to level of exposure. The UK was under lockdown during the period of the study with people requested to stay at home; we ran sensitivity analyses excluding the group likely to have had the greatest exposure to the virus -healthcare workers as they continued working throughout lockdown (UK Biobank codes 2211001-2216012, N=1665, of which 62 were tested (11 positive, 5 severe infection)).

All analyses were carried out in Stata version 16.0 (StataCorp LLC, TX, USA). Statistical significance was set at the alpha level of .05.

Data were available on 91,248 individuals, of whom 2,009 had been tested for COVID-19, 207 had a positive test result and 124 were classified as having a severe infection. Participant characteristics for both models are reported in Table 2 .

The results of the regression models are shown in Figure 1 and Table S1 . Results for severe infection (Figure 1a ) and positive test results (Figure 1b) were broadly consistent. Overall physical activity level and moderate-to-vigorous physical activity (MVPA) were not significantly associated with the risk of testing positive for SARS-CoV-2 or developing severe COVID-19. A higher amount of movement during the main sleep/rest period (least active 8 hours) (OR 1.14-1.26, p <.05) and lower activity during waking hours (model 1 only, OR 0.75 [95% CI: 0.61, 0.93], p=.01) were associated with increased odds independent of each other (i.e. both were significant in the same model). Consequently, a worse (lower) balance between activity and sleep/rest (i.e. a smaller drop in movement during the main sleep/rest period) was also predictive (OR 0.71-0.86, p<.05). Irregular sleeping patterns (greater variability in the start times of activity during waking hours, amount of movement J o u r n a l P r e -p r o o f during the main sleep/rest period , and mid-point of the difference between these times) were consistently associated with significantly greater odds (OR 1.17-1.21, p<.01) across both models. Results of unadjusted models were consistent with the adjusted models (Table S1. Sensitivity analyses broadly confirmed the associations: 1) if the least active 6 hours was as the main sleep/rest period instead of the least active 8 hours;

2) if individuals testing positive in the community were assumed to be non-severe and added to the comparator group for severe infection with SARS-CoV-2 ( Figure S1 );

3) with further adjustment for BMI (Model 1 and 2) and cancer and non-cancer illnesses (Model 1) ( Figure S2 ); 4) when excluding healthcare workers ( Figure S3 ).

The balance and variability in timing of activity and rest were more strongly associated with the risk of testing positive for SARS-CoV-2 or incidence of severe COVID-19 than 'standard' measures of activity, i.e. MVPA. This highlights the importance of not just physical activity alone, but also adequate quality sleep/rest. A distinct activity cycle (better balance between activity and rest), reflecting a clear drop in movement during the main sleep/rest period (one third of the day), was associated with a lower risk, independent of selfreported sleep duration. The importance of quality sleep/rest was further evident in the positive association between the level of movement during sleep/rest (the least active continuous 8 hours) and risk, independent of activity level during waking hours, in all models.

A better balance between activity and the dominant sleep/rest period (by 1 SD of the sample mean) was associated with approximately 30% lower risk of severe COVID-19. This more distinct activity cycle could reflect greater movement during waking hours (16 hours), less movement during the main sleep/rest period (8 hours), or both. For example, a 1 SD higher balance between activity and sleep/rest could reflect the equivalent of 90 minutes extra brisk walking [12] ; or lower movement during the main sleep/rest period by 1 SD (i.e. ~2 mg) of the sample mean; or ~45 minutes of brisk walking and lower movement during the main sleep/rest period by ~0.5 SD (i.e. ~1 mg) of the sample mean.

Sleep disruption and physical inactivity can contribute to chronic inflammation [13] and to cardiometabolic disease, which in turn is associated with an increased risk of COVID-19 [1] .

Further, as COVID-19 is an acute inflammatory disease, it may exacerbate existing chronic inflammation associated with poor activity and rest behaviours and/or existing cardiometabolic disease. Alongside other risk factors (e.g. psychological stress and genetic predisposition) this may be associated with a 'cytokine storm ' [13] contributing to the observed increased risk of severe COVID-19.

The consistently ~1.2 times higher risk of COVID-19 per ~40-minute increase in variability in timing of sleep/rest, indicative of irregular sleeping patterns, further supports that risk factors for cardiovascular and cardiometabolic disease [4, 5] are also risk factors for COVID-19 [2, 3] .

Characteristics of participants, including accelerometer data, were measured prior to the current pandemic. While the analyses were controlled for deprivation and household size, it was not possible to determine level of exposure to infection. However, results were robust J o u r n a l P r e -p r o o f To allow for differences in the duration of sleep, we conducted sensitivity analyses assessing the impact of the average acceleration and timing of the least active 6 h rather than 8 h A proxy for the balance between activity and rest/sleep in a 24 h day. A value of 100% would mean no distinction between activity and sleep/rest (i.e. no drop in movement levels during the main sleep/rest period). As the value gets closer to 150% it indicates an increasingly distinct activity/rest cycle with two thirds of the day active and one third resting. To allow for differences in the duration of sleep, we conducted sensitivity analyses assessing the impact of the average acceleration and timing of the least active 6 h rather than 8 h.

J o u r n a l P r e -p r o o f 

Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. International journal of infectious diseases

Obesity and risk of COVID-19: analysis of UK Biobank. Prim. Care Diabetes

Obesity, walking pace and risk of severe day (hh:mm)

Mid-point of difference between start of least active 8h and most active 16h (hh:mm

c Mid-point of difference between start of least active 6h and most active 16h

Continuous variables are reported as median (interquartile range), categorical variables as number (percentage) h = hour; mg = milli-gravitational units

Acknowledgements: Data were analysed using UK Biobank application number 36371.